Protagonist Therapeutics Inc (PTGX)
Financing Cash Flow
$9.74M
Quarterly · Period ending: · USD
PTGX Financing Cash Flow
Latest reported$9.74Mperiod ending
Latest reported$9.74Mperiod ending
PTGX Quarterly Cash from Financing ($2.00K → $9.74M)
Quarterly financing cash flow
High-resolution chart · PNG
PTGX financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 9,743,000 | |
| 23,374,000 | |
| 2,837,000 | |
| 5,659,000 | |
| 2,925,000 | |
| 11,443,000 | |
| 4,031,000 | |
| 12,051,000 | |
| 2,572,000 | |
| 7,199,000 | |
| 527,000 | |
| 35,315,000 | |
| 108,172,000 | |
| 26,463,000 | |
| 553,000 | |
| 680,000 | |
| 680,000 | |
| 16,925,000 | |
| 2,173,000 | |
| 1,381,000 | |
| 125,390,000 | |
| 979,000 | |
| 126,981,000 | |
| 7,669,000 | |
| 112,577,000 | |
| 399,000 | |
| 9,779,000 | |
| 25,237,000 | |
| 10,630,000 | |
| 390,000 | |
| 479,000 | |
| 23,032,000 | |
| 74,000 | |
| 530,000 | |
| 65,062,000 | |
| 31,000 | |
| 87,000 | |
| 374,000 | |
| -852,000 | |
| 85,278,000 | |
| -750,000 | |
| 22,631,000 | |
| 0 | |
| 17,362,000 | |
| 55,000 | |
| 2,000 |